Normal Laboratory Values of Blood, Plasma, Serum, Urine, CSF and Stool

Normal Laboratory Values: Blood, Plasma, and Serum

TestSpecimenConventional UnitsSI Units

Acetoacetate

Plasma

< 1 mg/dL

< 0.1 mmol/L

Acetylcholinesterase (ACE), RBC

Blood

26.7–49.2 U/g Hb

Acid phosphatase

Serum

0.5–5.5 U/L

0–0.9 μkat/L

Activated partial thromboplastin time (aPTT)

Plasma

25–35 sec

Adrenocorticotropic hormone (ACTH)

Serum

9–52 pg/mL

2–11 pmol/L

Albumin

Serum

3.5–5.5 g/dL

35–55 g/L

Aldosterone:   

Standing

Serum

7–20 ng/dL

194–554 pmol/L

Supine

Serum

2–5 ng/dL

55–138 pmol/L

Alkaline phosphatase (ALP)

Serum

36–92 U/L

0.5–1.5 μkat/L

Alpha1-antitrypsin (AAT)

Serum

83–199 mg/dL

Alpha fetoprotein (AFP)

Serum

0–20 ng/dL

0–20 pg/L

δ-Aminolevulinic acid (ALA)

Serum

15–23 μg/L

1.14–1.75 μmol/L

Aminotransferase, alanine (ALT)

Serum

0–35 U/L

0–0.58 pkat/L

Aminotransferase, aspartate (AST)

Serum

0–35 U/L

0–0.58 pkat/L

Ammonia

Plasma

40–80 μg/dL

23–47 μmol/L

Amylase

Serum

0–130 U/L

0–2.17 μkat/L

Antibodies to extractable nuclear antigen (AENA)

Serum

< 20.0 units

Anti–cyclic citrullinated peptide (anti-CCP) antibodies

Serum

≤ 5.0 units

Antidiuretic hormone (ADH; arginine vasopressin)

Plasma

< 1.7 pg/mL

< 1.57 pmol/L

Anti–double-stranded DNA (dsDNA) antibodies, IgG

Serum

< 25 IU

Antimitochondrial M2 antibodies

Serum

< 0.1 units

Antineutrophil cytoplasmic antibodies (cANCA)

Serum

Negative

Antinuclear antibodies (ANA)

Serum

≤ 1.0 units

Anti–smooth muscle antibodies (ASMA) titer

Serum

≤ 1:80

Antistreptolysin O titer

Serum

< 150 units

Antithyroid microsomal antibody titer

Serum

< 1:100

α1-Antitrypsin (AAT)

Serum

83–199 mg/dL

15.3–36.6 μmol/L

Apolipoproteins:   

A-I, females

Serum

98–210 mg/dL

0.98–2.1 g/L

A-I, males

Serum

88–180 mg/dL

0.88–1.8 g/L

B-100, females

Serum

44–148 mg/dL

0.44–1.48 g/L

B-100, males

Serum

55–151 mg/dL

0.55–1.51 g/L

Bicarbonate

Serum

23–28 mEq/L

23–28 mmol/L

Bilirubin:   

Direct

Serum

0–0.3 mg/dL

0–5.1 μmol/L

Total

Serum

0.3–1.2 mg/dL

5.1–20.5 μmol/L

Blood volume:   

Plasma, females

Blood

28–43 mL/kg body wt

0.028–0.043 L/kg body wt

Plasma, males

Blood

25–44 mL/kg body wt

0.025–0.044 L/kg body wt

RBCs, females

Blood

20–30 mL/kg body wt

0.02–0.03 L/kg body wt

RBCs, males

Blood

25–35 mL/kg body wt

0.025–0.035 L/kg body wt

Brain (B-type) natriuretic peptide (BNP)

Plasma

< 100 pg/mL

Calcitonin, age ≥ 16 yr:   

Females

Serum

< 8 pg/mL

Males

Serum

< 16 pg/mL

Calcium

Serum

9–10.5 mg/dL

2.2–2.6 mmol/L

Cancer antigen (CA):   

CA 125

Serum

< 35 U/mL

CA 15-3

Serum

< 30 U/mL

Carbon dioxide (CO2) content

Serum

23–28 mEq/L

23–28 mmol/L

Carbon dioxide partial pressure (PCO2)

Blood

35–45 mm Hg

Carboxyhemoglobin

Plasma

0.5–5%

Carcinoembryonic antigen (CEA)

Serum

< 2 ng/mL

< 2 μg/L

Carotene

Serum

75–300 μg/L

1.4–5.6 μmol/L

CD4:CD8 ratio

Blood

1–4

CD4+ T-cell count

Blood

640–1175/μL

0.64–1.18 x 109/L

CD8+ T-cell count

Blood

335–875/μL

0.34–0.88 x 109/L

Ceruloplasmin

Serum

25–43 mg/dL

250–430 mg/L

Chloride

Serum

98–106 mEq/L

98–106 mmol/L

Cholesterol, desirable level:   

High-density lipoprotein (HDL-C)

Plasma

≥ 40 mg/dL

≥ 1.04 mmol/L

Low-density lipoprotein (LDL-C)

Plasma

≤ 130 mg/dL

≤ 3.36 mmol/L

Total (TC)

Plasma

150–199 mg/dL

3.88–5.15 mmol/L

Coagulation factors:   

Factor I

Plasma

150–300 mg/dL

1.5–3.5 g/L

Factor II

Plasma

60–150% of normal

Factor IX

Plasma

60–150% of normal

Factor V

Plasma

60–150% of normal

Factor VII

Plasma

60–150% of normal

Factor VIII

Plasma

60–150% of normal

Factor X

Plasma

60–150% of normal

Factor XI

Plasma

60–150% of normal

Factor XII

Plasma

60–150% of normal

Complement:   

C3

Serum

55–120 mg/dL

0.55–1.20 g/L

C4

Serum

20–59 mg/dL

0.20–0.59 g/L

Total

Serum

37–55 U/mL

37–55 kU/L

Copper

Serum

70–155 μg/L

11–24.3 μmol/L

Cortisol:   

1 h after cosyntropin

Serum

> 18 μg/dL and usually ≥ 8 μg/dL above baseline

> 498 nmol/L and usually ≥ 221 nmol/L above baseline

At 5 pm

Serum

3–13 μg/dL

83–359 nmol/L

At 8 am

Serum

8–20 μg/dL

251–552 nmol/L

After overnight suppression test

Serum

< 5 μg/dL

< 138 nmol/L

C-peptide

Serum

0.9–4.3 ng/mL

297–1419 pmol/L

C-reactive protein (CRP)

Serum

< 0.5 mg/dL

< 0.005 g/L

C-reactive protein, highly sensitive (hsCRP)

Serum

< 1.1 mg/L

< 0.0011 g/L

Creatine kinase (CK)

Serum

30–170 U/L

0.5–2.83 μkat/L

Creatinine

Serum

0.7–1.3 mg/dL

61.9–115 μmol/L

d-Dimer

Plasma

≤ 300 ng/mL

≤ 300 μg/L

Dehydroepiandrosterone sulfate (DHEA-S):   

Females

Plasma

0.6–3.3 mg/mL

1.6–8.9 μmol/L

Males

Plasma

1.3–5.5 mg/mL

3.5–14.9 μmol/L

δ-Aminolevulinic acid (ALA)

Serum

15–23 μg/L

1.14–1.75 μmol/L

11-Deoxycortisol (DOC):   
After metyrapone

 

Plasma

> 7 μg/dL

> 203 nmol/L

Basal

Plasma

< 5 μg/dL

< 145 nmol/L

d-Xylose level 2 h after ingestion of 25 g of d-xylose

Serum

> 20 mg/dL

> 1.3 nmol/L

Epinephrine, supine

Plasma

< 75 ng/L

< 410 pmol/L

Erythrocyte sedimentation rate (ESR):   

Females

Blood

0–20 mm/h

0–20 mm/h

Males

Blood

0–15 mm/h

0–20 mm/h

Erythropoietin

Serum

4.0–18.5 mIU/mL

4.0–18.5 IU/L

Estradiol, females:   

Day 1–10 of menstrual cycle

Serum

14–27 pg/mL

50–100 pmol/L

Day 11–20 of menstrual cycle

Serum

14–54 pg/mL

50–200 pmol/L

Day 21–30 of menstrual cycle

Serum

19–40 pg/mL

70–150 pmol/L

Estradiol, males

Serum

10–30 pg/mL

37–110 pmol/L

Ferritin

Serum

15–200 ng/mL

15–200 μg/L

α-Fetoprotein (AFP)

Serum

0–20 ng/dL

0–20 pg/L

Fibrinogen

Plasma

150–350 mg/dL

1.5–3.5 g/L

Folate (folic acid):   

RBC

Blood

160–855 ng/mL

362–1937 nmol/L

Serum

Serum

2.5–20 ng/mL

5.7–45.3 nmol/L

Follicle-stimulating hormone (FSH), females:   

Follicular or luteal phase

Serum

5–20 mU/mL

5–20 U/L

Midcycle peak

Serum

30–50 mU/mL

30–50 U/L

Postmenopausal

Serum

> 35 mU/mL

> 35 U/L

Follicle-stimulating hormone (FSH), adult males

Serum

5–15 mU/mL

5–15 U/L

Fructosamine

Plasma

200–285 mol/L

Gamma-glutamyl transpeptidase (GGT)

Serum

8–78 U/L

Gastrin

Serum

0–180 pg/mL

0–180 ng/L

Globulins:

Serum

2.5–3.5 g/dL

25–35 g/L

α1-Globulins

Serum

0.2–0.4 g/dL

2–4 g/L

α2-Globulins

Serum

0.5–0.9 g/dL

5–9 g/L

β-Globulins

Serum

0.6–1.1 g/dL

6–11 g/L

γ-Globulins

Serum

0.7–1.7 g/dL

7–17 g/L

β2-Microglobulin

Serum

0.7–1.8 μg/mL

Glucose:   

2-h postprandial

Plasma

< 140 mg/dL

< 7.8 mmol/L

Fasting

Plasma

70–105 mg/dL

3.9–5.8 mmol/L

Glucose-6-phosphate dehydrogenase (G6PD)

Blood

5–15 U/g Hb

0.32–0.97 mU/ mol Hb

γ-Glutamyl transpeptidase (GGT)

Serum

8–78 U/L

Growth hormone:   

After oral glucose

Plasma

< 2 ng/mL

< 2 μg/L

In response to provocative stimuli

Plasma

> 7 ng/mL

> 7 μg/L

Haptoglobin

Serum

30–200 mg/dL

300–2000 mg/L

Hematocrit:   

Females

Blood

36–47%

Males

Blood

41–51%

Hemoglobin:   

Females

Blood

12–16 g/dL

120–160 g/L

Males

Blood

14–17 g/dL

140–170 g/L

Hemoglobin A1c

Blood

4.7–8.5%

Hemoglobin electrophoresis, adults:   

Hb A1

Blood

95–98%

Hb A2

Blood

2–3%

Hb C

Blood

0%

Hb F

Blood

0.8–2.0%

Hb S

Blood

0%

Hemoglobin electrophoresis, Hb F in children:   

Neonate

Blood

50–80%

1–6 mo

Blood

8%

> 6 mo

Blood

1–2%

Homocysteine:   

Females

Plasma

0.40–1.89 mg/L

3–14 μmol/L

Males

Plasma

0.54–2.16 mg/L

4–16 μmol/L

Human chorionic gonadotropin (hCG), quantitative

Serum

< 5 mIU/mL

Immunoglobulins:   

Serum

70–300 mg/dL

0.7–3.0 g/L

Serum

< 8 mg/dL

< 80 mg/L

Serum

0.01–0.04 mg/dL

0.1–0.4 mg/L

Serum

640–1430 mg/dL

6.4–14.3 g/L

IgG1

Serum

280–1020 mg/dL

2.8–10.2 g/L

IgG2

Serum

60–790 mg/dL

0.6–7.9 g/L

IgG3

Serum

14–240 mg/dL

0.14–2.4 g/L

IgG4

Serum

11–330 mg/dL

0.11–3.3 g/L

Serum

20–140 mg/dL

0.2–1.4 g/L

Insulin, fasting

Serum

1.4–14 μIU/mL

10–104 pmol/L

International normalized ratio (INR):   

Therapeutic range (standard intensity therapy)

Plasma

2.0–3.0

Therapeutic range in patients at higher risk (eg, patients with prosthetic heart valves)

Plasma

2.5–3.5

Therapeutic range in patients with lupus anticoagulant

Plasma

3.0–3.5

Iron

Serum

60–160 μg/dL

11–29 μmol/L

Iron-binding capacity, total (TIBC)

Serum

250–460 μg/dL

45–82 μmol/L

Lactate dehydrogenase (LDH)

Serum

60–160 U/L

1–1.67 μkat/L

Lactic acid, venous

Blood

6–16 mg/dL

0.67–1.8 mmol/L

Lactose tolerance test

Plasma

> 15 mg/dL increase in plasma glucose level

> 0.83 mmol/L increase in plasma glucose level

Lead

Blood

< 40 μg/dL

< 1.9 μmol/L

Leukocyte alkaline phosphatase (LAP) score

Peripheral blood smear

13–130/100/ polymorphonuclear (PMN) leukocyte neutrophils and bands

Lipase

Serum

< 95 U/L

< 1.58 μkat/L

Lipoprotein (a) [Lp(a)]

Serum

≤ 30 mg/dL

< 1.1 μmol/L

Luteinizing hormone (LH), females:   

Follicular or luteal phase

Serum

5–22 mU/mL

5–22 U/L

Midcycle peak

Serum

30–250 mU/mL

30–250 U/L

Postmenopausal

Serum

> 30 mU/mL

> 30 U/L

Luteinizing hormone, males

Serum

3–15 mU/mL

3–15 U/L

Magnesium

Serum

1.5–2.4 mg/dL

0.62–0.99 mmol/L

Manganese

Serum

0.3–0.9 ng/mL

5.5–16.4 nmol/L

Mean corpuscular hemoglobin (MCH)

Blood

28–32 pg

Mean corpuscular hemoglobin concentration (MCHC)

Blood

32–36 g/dL

320–360 g/L

Mean corpuscular volume (MCV)

Blood

80–100 fL

Metanephrines, fractionated:   

Metanephrines, free

Plasma

< 0.50 nmol/L

Normetanephrines, free

Plasma

< 0.90 nmol/L

Methemoglobin

Blood

< 1.0%

Methylmalonic acid (MMA)

Serum

150–370 nmol/L

Myeloperoxidase (MPO) antibodies

Serum

< 6.0 U/mL

Myoglobin:   

Females

Serum

25–58 μg/L

1.4–3.5 nmol/L

Males

Serum

28–72 μg/L

1.6–4.1 nmol/L

Norepinephrine, supine

Plasma

50–440 pg/mL

0.3–2.6 nmol/L

N-Terminal propeptide of BNP (NT-proBNP)

Plasma

< 125 pg/mL

5′-Nucleotidase (5’NT)

Serum

4–11.5 U/L

Osmolality

Plasma

275–295 mOsm/kg H2O

275–295 mmol/ kg H2O

Osmotic fragility test

Blood

Increased fragility if hemolysis occurs in > 0.5% NaCl

Decreased fragility if hemolysis is incomplete in 0.3% NaCl

Oxygen partial pressure (PO2)

Blood

80–100 mm Hg

Parathyroid hormone (PTH)

Serum

10–65 pg/mL

10–65 ng/L

Parathyroid hormone–related peptide (PTHrP)

Plasma

< 2.0 pmol/L

Partial thromboplastin time, activated (aPTT)

Plasma

25–35 sec

pH

Blood

7.38–7.44

Phosphorus, inorganic

Serum

3.0–4.5 mg/dL

0.97–1.45 mmol/L

Platelet count

Blood

150–350 x 103/μL

150–350 x 109/L

Platelet life span, using chromium-51 (51Cr)

8–12 days

Porphyrins

Plasma

≤ 1.0 μg/dL

Potassium

Serum

3.5–5 mEq/L

3.5–5 mmol/L

Prealbumin (transthyretin)

Serum

18–45 mg/dL

Progesterone:   

Follicular phase

Serum

< 1 ng/mL

< 0.03 nmol/L

Luteal phase

Serum

3–30 ng/mL

0.1–0.95 nmol/L

Prolactin:   

Females

Serum

< 20 μg/L

< 870 pmol/L

Males

Serum

< 15 μg/L

< 652 pmol/L

Prostate-specific antigen, total (PSA-T)

Serum

0–4 ng/mL

Prostate-specific antigen, ratio of free to total (PSA-F:PSA-T)

Serum

> 0.25

Protein C activity

Plasma

67–131%

Protein C resistance, activated ratio (APC-R)

Plasma

2.2–2.6

Protein S activity

Plasma

82–144%

Protein, total

Serum

6–7.8 g/dL

60–78 g/L

Prothrombin time (PT)

Plasma

11–13 sec

Pyruvate

Blood

0.08–0.16 mmol/L

RBC count

Blood

4.2–5.9 x 106 cells/μL

4.2–5.9 x 1012cells/L

RBC survival rate, using 51Cr

Blood

T1/2 = 28 days

Renin activity, plasma (PRA), upright, in males and females aged 18–39 yr:   

Sodium-depleted

Plasma

2.9–24 ng/mL/h

Sodium-repleted

Plasma

0.6 (or lower)–4.3 ng/mL/h

Reticulocyte count:   

Percentage

Blood

0.5–1.5%

Absolute

Blood

23–90 x 103/μL

23–90 x 109/L

Rheumatoid factor (RF)

Serum

< 40 U/mL

< 40 kU/L

Sodium

Serum

136–145 mEq/L

136–145 mmol/L

Testosterone, adults:   

Females

Serum

20–75 ng/dL

0.7–2.6 nmol/L

Males

Serum

300–1200 ng/dL

10–42 nmol/L

Thrombin time

Plasma

18.5–24 sec

Thyroid iodine-123 (123I) uptake

5–30% of administered dose at 24 h

Thyroid-stimulating hormone (TSH)

Serum

0.5–5.0 μIU/mL

0.5–5.0 mIU/L

Thyroxine (T4):   

Free

Serum

0.9–2.4 ng/dL

12–31 pmol/L

Free index

4–11 μg/dL

Total

Serum

5–12 μg/dL

64–155 nmol/L

Transferrin

Serum

212–360 mg/dL

2.1–3.6 g/L

Transferrin saturation

Serum

20–50%

Triglycerides (desirable level)

Serum

< 250 mg/dL

< 2.82 mmol/L

Triiodothyronine (T3):   

Uptake

Serum

25–35%

Total

Serum

70–195 ng/dL

1.1–3.0 nmol/L

Troponin I

Plasma

< 0.1 ng/mL

< 0.1 μg/L

Troponin T

Serum

≤ 0.03 ng/mL

≤ 0.03 μg/L

Urea nitrogen (BUN)

Serum

8–20 mg/dL

2.9–7.1 mmol/L

Uric acid

Serum

2.5–8 mg/dL

0.15–0.47 mmol/L

Vitamin B12

Serum

200–800 pg/mL

148–590 pmol/L

Vitamin C (ascorbic acid):   

Leukocyte

Blood

< 20 mg/dL

< 1136 μmol/L

Total

Blood

0.4–1.5 mg/dL

23–85 μmol/L

Vitamin D:   
1,25-Dihydroxycholecalciferol (calcitriol)

 

Serum

25–65 pg/mL

65–169 pmol/L

25-Hydroxycholecalciferol

Serum

15–80 ng/mL

37–200 nmol/L

WBC count

Blood

3.9–10.7 x 103 cells/μL

3.9–10.7 x 109cells/L

Zinc

Serum

66–110 μg/dL

10.1–16.8 μmol/L

μkat = microkatal; pkat = picokatal.

Normal Laboratory Values of Blood, Plasma, Serum, Urine, CSF and Stool

Normal Laboratory Values: Urine

TestSpecimenConventional UnitsSI Units

Aldosterone

Urine, 24 h

5–19 μg/24 h

13.9–52.6 nmol/24 h

Amino acids, total

Urine, 24 h

200–400 mg/24 h

14–29 nmol/24 h

Amylase

Urine, timed

6.5–48.1 U/h

Calcium, with patients on an unrestricted diet

Urine, timed

100–300 mg/day

2.5–7.5 mmol/day

Catecholamines, total

Urine, 24 h

< 100 μg/m2/24 h

< 591 nmol/m2/24 h

Chloride

Urine, timed

80–250 mEq/day

80–250 mmol/day

Copper

Urine, 24 h

0–100 μg/24 h

0–1.6 μmol/24 h

Coproporphyrin

Urine, 24 h

50–250 μg/24 h

76–382 nmol/24 h

Cortisol, free

Urine, 24 h

< 90 μg/24 h

< 248 nmol/24 h

Creatine:

   

Females

Urine, 24 h

0–100 mg/24 h

0–763 mmol/24 h

Males

Urine, 24 h

4–40 mg/24 h

30–305 mmol/24 h

Creatinine, weight-based

Urine, 24 h

15–25 mg/kg/24 h

133–221 mmol/kg/ 24 h

d-Xylose excretion 5 h after ingestion of 25 g of d-xylose

Urine, 5 h collection

5–8 g

33–53 mmol

Estriol, females

Urine, 24 h

> 12 mg/24 h

> 42 μmol/24 h

17-Hydroxycorticosteroids, fractionated, adults ≥ 18 yr:

   

Cortisol

Urine, 24 h

3.5–4.5 μg/24 h

9.7–12.4 nmol/24 h

Cortisone

Urine, 24 h

17–129 μg/24 h

47–359 nmol/24 h

5-Hydroxyindoleacetic acid (5-HIAA)

Urine, 24 h

2–9 mg/24 h

10.4–46.8 μmol/24 h

17-Ketosteroid, fractionated, females > 12 yr:

   

Androsterone

Urine, 24 h

55–1589 μg/24 h

Pregnanetriol

Urine, 24 h

59–1391 μg/24 h

17-Ketosteroid, fractionated, males > 12 yr:

   

Androsterone

Urine, 24 h

234–2703 μg/24 h

Etiocholanolone

Urine, 24 h

151–3198 μg/24 h

11-Hydroxyandrosterone

Urine, 24 h

66–1032 μg/24 h

11-Hydroxyetiocholanolone

Urine, 24 h

17–1006 μg/24 h

11-Ketoandrosterone

Urine, 24 h

4–55 μg/24 h

11-Ketoetiocholanolone

Urine, 24 h

51–1016 μg/24 h

Pregnanetriol

Urine, 24 h

245–1701 μg/24 h

Metanephrines, fractionated, normotensive patients ≥ 18 yr:

   

Females, metanephrine

Urine, 24 h

30–180 μg/24 h

Females, total metanephrines

Urine, 24 h

142–510 μg/24 h

Males, metanephrine

Urine, 24 h

44–261 μg/24 h

Males, total metanephrines

Urine, 24 h

190–583 μg/24 h

Metanephrines, fractionated, normotensive males and females aged 18–29 yr:

   

Normetanephrine

Urine, 24 h

103–390 μg/24 h

Metanephrines, fractionated, hypertensive males and females:

   

Metanephrine

Urine, 24 h

< 400 μg/24 h

Normetanephrine

Urine, 24 h

< 900 μg/24 h

Total metanephrines

Urine, 24 h

< 1300 μg/24 h

Microalbumin

Urine, 24 h

< 30 mg/24 h

Microalbumin, albumin/ creatinine ratio

Urine, random

< 20 μg/mg

Osmolality

Urine, random

38–1400 mOsm/kg H2O

Oxalate

Urine, 24 h

0.11–0.46 mmol/ specimen*

Phosphate, tubular reabsorption

Urine, random

79–94% of filtered load

Porphobilinogens

Urine, random

0–0.5 mg/g creatinine

Potassium

Urine, 24 h

25–100 mEq/24 h

25–100 mmol/24 h

Protein, total

Urine, 24 h

< 100 mg/24 h

Sodium

Urine, 24 h

100–260 mEq/24 h

100–260 mmol/24 h

Uric acid

Urine, 24 h

250–750 mg/24 h

1.48–4.43 mmol/24 h

Urinalysis, routine

   

pH

Urine, random

5–7

Urinalysis, routine, dipstick testing:

   

Bilirubin

Urine, random

Negative

Blood

Urine, random

Negative

Glucose

Urine, random

Negative

Ketones

Urine, random

Negative

Leukocyte esterase

Urine, random

Negative

Nitrites

Urine, random

Negative

Protein

Urine, random

Negative

Urobilinogen

Urine, random

0.2–1.0 EU

Urobilinogen

Urine, 24 h

0.05–2.5 mg/24 h

0.08–4.22 μmol/24 h

Vanillylmandelic acid (VMA)

Urine, 24 h

< 8 mg/24 h

< 40.4 mol/24 h

*Value is based on 24-h collection.Normal findings detected by microscopic examination can include a few RBCs (especially in menstruating women), WBCs, epithelial cells, bacteria, yeast cells, crystals (eg, Ca oxalate, triple phosphate, amorphous phosphates and urates), sperm, and unidentifiable materials. Large amounts of these substances or the presence of certain other materials may be abnormal.

EU = Ehrlich units.

Normal Laboratory Values: CSF

TestConventional UnitsSI Units

Cell count

0–5 cells/μL

0–0.5 x 106 cells/L

Glucose

40–80 mg/dL (< 40% of simultaneously measured plasma level if that plasma level is abnormal)

2.5–4.4 mmol/L (< 40% of simultaneously measured plasma level is abnormal)

Myelin basic protein

< 1.5 ng/mL

Protein, total

15–60 mg/dL

150–600 mg/L

Normal Laboratory Values: Stool

TestConventional UnitsSI Units

Fat

< 5 g/day in patients on a 100-g fat diet

Nitrogen

< 2 g/day

Urobilinogen

40–280 mg/24 h

68–473 mg/24 h

Weight

< 200 g/day

Source: The Merck Manual

Similar Posts:

2 thoughts on “Normal Laboratory Values of Blood, Plasma, Serum, Urine, CSF and Stool”

  1. Dear Sagar

    Thank you for your interesting posts. Don’t you think the term “normal value” is better to change with “Reference Interval” as explained in CLSI and ISO terminology?

    Reply
  2. Sagar,
    This is very impressive and shows passion for the profession on your side. What a commendable effort to make such a compilation for sharing. However may I know if a global geographical distribution difference was calculated as it has proved in my over 35 years of service in the field that blood value (normal) range from caucasian communities are not the same with the Afro-comminities. All the same your effort,once again,is very commendable.

    Reply

Leave a Comment